Articles related to GLYCEMIC CONTROL

The latest research provides evidence that non-sugar sweeteners do not enhance appetite and can lower blood sugar and insulin levels post-consumption, which may be significant in managing metabolic health.

This study sheds light on lixisenatide’s potential in Parkinson’s disease, showing a notable slowing of motor disability progression, although accompanied by gastrointestinal side effects, underlining the importance of further research to validate these findings.

SGLT-2 inhibitors have emerged as a cornerstone in managing HFrEF and CKD, demonstrating substantial reductions in cardiovascular and renal adverse outcomes. This class of medications is reshaping the therapeutic approach in patients with these comorbid conditions, providing a dual benefit that was once considered challenging to achieve.

Understanding the dietary interactions with metformin is essential for healthcare providers to maximize the drug’s efficacy in Type 2 diabetes management. Tailoring diet recommendations can significantly influence patient outcomes and drug tolerance.

GLP-1 agonists are increasingly recognized for their dual benefits in type 2 diabetes management and cardiovascular risk reduction, offering a multifaceted approach to patient care in an expanding global market.

This article illustrates a case of bullosis diabeticorum, spotlighting the condition’s clinical presentation, diagnosis, and management, offering key insights for physicians in the early detection and care of this rare diabetic complication.